Merck CEO: Alzheimer’s Tsunami Coming
By Matthew Wisner Published January 10, 2017 Business Leaders FOXBusinessOpens a New Window. Merck CEO: Seeing ‘revolutionary change’ in the cure for cancer Merck CEO Ken Frazier on the company’s drug pipeline, the research into Alzheimer’s drugs, drug pricing, potential acquisitions and the areas of growth for the company. As society is living longer and longer, the risks of diseases such as Alzheimer’s are becoming even greater. Of the 5.4 million Americans with Alzheimer’s, an estimated 5.2 million people are age 65 and older, according to the Alzheimer’s Association. And as more Baby Boomers age that number may triple to 13 million by 2050. “At 85 you have a one in three chance of getting Alzheimer’s or that form of dementia, so this is an incredible tsunami that’s hitting our society given the fact that people are living longer,” said Merck CEO Ken Frazier (MRK) during an appearance with the […]